The proteomic approach identified differential expression of proteins previously linked with aggressive clinical outcome in bladder tumors: gelsolin [49], moesin [32], Ezrin [50], caveolin [32], Filamin A [33]. The gene discussed is MSN; the disease is urinary bladder neoplasm.